Home

Differential
Counter

Flow
Tutorial

 

 
 
Myeloproliferative
neoplasms
Neoplasms with eosinophilia
(PDGRA/PDGFRB/FGFR1)
MDS/MPN MDS AML Acute leukemia
ambiguous lineage
Precursor lymphoid
neoplasms
Mature B cell
neoplasms
Mature T and NK
neoplasms
Hodgkin
lymphoma
Immunodeficiency associated
lymphoproliferative disorders
Histiocytic and dendritic
cell neoplasms
 

Lymphoplasmacytic Lymphoma

  Unusual antigen expression abstracts Prognostic abstracts Cytogenetic abstracts Antigen chart
CLL/SLL
 B cell prolymphocytic leukemia
Splenic B cell marginal zone lymphoma
Hairy cell leukemia
Splenic B cell lymphoma / leukemia
Lymphoplasmacytic lymphoma
Heavy chain disease
Plasma cell neoplasms
Extranodal marginal zone lymphoma of mucosa associated lymphoid tissue
Nodal marginal zone lymphoma
Follicular lymphoma
Primary cutaneous follicle center lymhoma
Mantle cell lymphoma
Diffuse large B cell lymphoma
DLBCL associated with chronic inflammation
Lymphomatoid granulomatosis
Primary mediastinal large B cell lymphoma
Intravascular large B cell lymphoma
ALK positive large B cell lymphoma
Plasmablastic lymphoma
Large B cell lymphoma - HHV8 associated multicentric Castleman
Primary effusion lymphoma
Burkitt lymphoma
B cell lymphoma, unclassifiable with features of DLBCL and Burkitt
B cell lymphoma, unclassifiable with features of DLBCL and Hodgkin
Article Antigens evaluated
CD52 expression in Waldenstrom's macroglobulinemia: implications for alemtuzumab therapy and response assessment. CD52